Search Results - "Bátovský, Marian"
-
1
Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease
Published in Gastroenterology (New York, N.Y. 1943) (01-02-2011)“…Background & Aims Comparative data on budesonide vs mesalamine for the treatment of mild-to-moderately active Crohn's disease (CD) are sparse. We assessed the…”
Get full text
Journal Article -
2
Effect of home parenteral nutrition in malnourished patients
Published in Bratislavské lékarské listy (01-01-2023)“…The goal of our research was to determine the impact of clinical nutrition in the form of home parenteral nutrition (HPN) in patients with nutritional…”
Get full text
Journal Article -
3
-
4
391 Both Budesonide (9mg) As Well As High-Dose Eudragit-L-Coated Mesalamine (4.5g) Lead to High Remission Rates in Moderately Active Crohn's Disease Patients: A Double-Blind, Double-Dummy, Randomized, Multicenter Study
Published in Gastroenterology (New York, N.Y. 1943) (2009)Get full text
Journal Article -
5
Gene Polymorphisms Involved in Manifestation of Leucopenia, Digestive Intolerance, and Pancreatitis in Azathioprine-Treated Patients
Published in Digestive diseases and sciences (01-09-2012)“…Background Approximately 10–28 % of patients experience adverse drug reactions related to treatment with thiopurines. The most serious reaction is…”
Get full text
Journal Article -
6
-
7
Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity
Published in Neuro-endocrinology letters (2009)“…Our study aims to find the relationship between metabolic enzyme thiopurine S-methyltransferase (TPMT) gene polymorphisms and clinical output of the therapy…”
Get more information
Journal Article